Literature DB >> 34248170

Ceftriaxone-Induced Pancreatitis.

Muneerah M Albugami1, Mohamed Ahmed2, Abdulelah Bin Shihah3.   

Abstract

Entities:  

Year:  2021        PMID: 34248170      PMCID: PMC8237964          DOI: 10.4212/cjhp.v74i3.3157

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


× No keyword cloud information.
  15 in total

1.  Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.

Authors:  Shinya Murata; Tomoki Aomatsu; Atsushi Yoden; Hiroshi Tamai
Journal:  Pediatr Int       Date:  2015-07-21       Impact factor: 1.524

2.  Gallstone pancreatitis caused by ceftriaxone.

Authors:  M C Maranan; S I Gerber; G G Miller
Journal:  Pediatr Infect Dis J       Date:  1998-07       Impact factor: 2.129

3.  Drug-induced pancreatitis: an update.

Authors:  Chirag D Trivedi; C S Pitchumoni
Journal:  J Clin Gastroenterol       Date:  2005-09       Impact factor: 3.062

Review 4.  Drug-induced acute pancreatitis related to medications commonly used in gastroenterology.

Authors:  Dorota Ksiądzyna
Journal:  Eur J Intern Med       Date:  2010-10-13       Impact factor: 4.487

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

Review 6.  Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication.

Authors:  G Famularo; S Polchi; C De Simone
Journal:  Ann Ital Med Int       Date:  1999 Jul-Sep

7.  Ceftriaxone-induced pancreatitis in a pediatric patient: case report.

Authors:  S Ruggiero; R DI Nardo; T Polimeno; F Rossi; A Capuano
Journal:  J Chemother       Date:  2010-02       Impact factor: 1.714

Review 8.  Drug-induced acute pancreatitis: an evidence-based review.

Authors:  Nison Badalov; Robin Baradarian; Kadirawel Iswara; Jianjun Li; William Steinberg; Scott Tenner
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03-28       Impact factor: 11.382

9.  Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction.

Authors:  Aya Imafuku; Naoki Sawa; Akinari Sekine; Masahiro Kawada; Rikako Hiramatsu; Masayuki Yamanouchi; Eiko Hasegawa; Noriko Hayami; Jyunichi Hoshino; Yoshifumi Ubara; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2017-10-12       Impact factor: 2.801

10.  A case of ceftriaxone-associated biliary pseudolithiasis in an elderly patient with renal dysfunction.

Authors:  Shuichi Abe
Journal:  IDCases       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.